Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review.
Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review.
复制标题
DOI:
10.1016/j.jacc.2021.07.042
复制
发表时间:
2021-09-28
影响因子:
24
通讯作者:
Crea F
中科院分区:
文献类型:
--
作者:
Del Buono MG;Montone RA;Camilli M;Carbone S;Narula J;Lavie CJ;Niccoli G;Crea F
Coronary microvascular dysfunction (CMD) encompasses several pathogenetic mechanisms involving coronary microcirculation and plays a major role in determining myocardial ischemia in patients with angina without obstructive coronary artery disease (CAD), as well as in several other conditions, including obstructive CAD, non-ischemic cardiomyopathies, Takotsubo syndrome and heart failure, especially the phenotype associated with preserved ejection fraction. Unfortunately, despite the identified pathophysiological and prognostic role of CMD in several conditions, to date, there is no specific treatment for CMD. Due to the emerging role of CMD as common denominator in different clinical phenotypes, additional research in this area is warranted in order to provide personalized treatments in this “garden variety” of patients. The purpose of this review is to describe the pathophysiological mechanisms of CMD and its mechanistic and prognostic role across different cardiovascular diseases. We will also discuss diagnostic modalities and the potential therapeutic strategies resulting from recent clinical studies. Coronary microvascular dysfunction (CMD) is prevalent across several cardiovascular conditions. The emerging role of CMD as common denominator in different clinical entities, calls for addressing knowledge gaps for the management of these heterogeneous patients with evidence of CMD. We revise the pathophysiological mechanisms of CMD, its prognostic role across different cardiovascular diseases, the diagnostic modalities commonly used in clinical practice and the potential therapeutic strategies for optimal patient management.
登录
查看更多内容
影响因子:
2.8
作者:
Chen, JW;Hsu, NW;Chang, MS
通讯作者:
Chang, MS
影响因子:
24
作者:
Cuisset, Thomas;Hamilos, Michatis;De Bruyne, Bernard
通讯作者:
De Bruyne, Bernard
影响因子:
9.3
作者:
Adingupu, Damilola D.;Gopel, Sven O.;Jonsson-Rylander, Ann-Cathrine
通讯作者:
Jonsson-Rylander, Ann-Cathrine
影响因子:
18.2
作者:
Ahmad, Ali;Corban, Michel T.;Lerman, Amir
通讯作者:
Lerman, Amir
DOI:
10.1016/j.jchf.2014.03.009
发表时间:
2014-08
期刊:
JACC. Heart failure
影响因子:
--
作者:
Dorbala S;Vangala D;Bruyere J Jr;Quarta C;Kruger J;Padera R;Foster C;Hanley M;Di Carli MF;Falk R
通讯作者:
Falk R